THOMAS BORGSTEDTE: Open Payments
NPI 1295877264 · LA GRANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 54 payments from 19 companies in 2025. Trend: 2023 $640 · 2024 $809 · 2025 $974
Food & beverage: $950Entertainment: $14Education: $10
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $150 |
| ABBVIE INC. | 10 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $135 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Corcept Therapeutics | 3 | $80 |
| DePuy Synthes Sales Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Antares Pharma, Inc. | 2 | $42 |
| Dexcom, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $28 |
Products named: JARDIANCE, OTEZLA, VRAYLAR, Korlym, TRELEGY ELLIPTA, SHINGRIX, XYOSTED, MONOVISC.
Industry payments across TX — which companies pay providers there.
